Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Adaptive Biotechnologies Q2 EPS USD -0.25

BRIEF-Adaptive Biotechnologies Q2 EPS USD -0.25

ReutersReuters2026/07/29 20:06
By:Reuters

Jul 29 (Reuters) - Adaptive Biotechnologies Q2 revenue USD 71.553 million vs. IBES estimate USD 65.9 million.

  • Q2 operating expenses USD 87.323 million
  • Q2 net income USD -39.941 million
  • Q2 operating income USD -15.77 million
  • Q2 adjusted EBITDA USD -700 thousand
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!